Past Events

CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives.

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.

Successful applicants will receive funding of up to $400,000 USD over 2 years.

Interested researchers are invited to:

• Attend information webinars to learn more about the initiative: Thursday, January 23 at 1pm ET or Wednesday, February 5, at 11am ET
• Contact James Bellush at jmb824@cornell.edu to express interest in applying and to obtain online application submission instructions.
• Submit a non-confidential, 300 word abstract via the CSL online application portal by February 20, 2025.

Ignite Connect: Accelerating Impact is a new signature event of the Ignite Cornell Lab to Market program series. This virtual event serves as a unique venue to connect investors, industry partners, and stakeholders with technology innovations and companies that have benefited from the Ignite Gap Funding Program. 

It is an opportunity to explore and engage with researchers and founders around their technologies and ventures emerging from Cornell University. This dynamic virtual experience aims to create connections and serves as a catalyst, bridging innovative technologies with resources and opportunities for meaningful impact.

Register now. 

Fresh off the heels of last Tuesday's successful Weill Cornell Medicine Cores Day, we are excited to share the next installment of BioVenture eLab’s and Ford Center Incubator’s Core Facilities Series. This episode will focus on physician-scientists and an essential resource for innovation testing and cross-discipline training.

Featured Guest:

Kevin Ching, M.D.

• Medical Director, Weill Cornell Medicine and NewYork-Presbyterian Simulation Center
• Assistant Attending Physician
• Associate Professor, Emergency Medicine & Pediatrics

The WCM and NYP Simulation Center is a leader in interprofessional, experiential healthcare education. As a comprehensive and integrated partnership between the Departments of Emergency Medicine, Internal Medicine, OB-GYN, and Pediatrics, this core facility strives to reinvent how knowledge is shared through simulation-based education. The center creates and develops innovations in interprofessional education, collaborative research and patient safety.

Discover more about its experiential learning opportunities for: 

• Patient safety initiatives
• Interprofessional teamwork behaviors
• Advanced life support skills
• Advanced airway procedures
• Trauma resuscitation skills
• ACGME core competencies

Hosts

Loren A. Busby, CFA, Director, Weill Cornell Medicine BioVenture eLab
Carlo Yuvienco, PhD, Director, Ford Center Incubator @ The Rockefeller University

 Register here. 

In the past, obtaining an issued patent from the U.S. Patent and Trademark Office usually meant wrangling with a patent examiner over the pillars of patentability, novelty and obviousness. However, the Supreme Court's 2023 decision in Amgen v. Sanofi thrust another lesser-known condition, the enablement requirement, to the forefront. Citing the enablement requirement, the Court curtailed the breadth of the Amgen's patent claims, stating that the specification did not support their broad claims to classes of molecules. In the aftermath, inventors, patent holders and practitioners have been left scrambling to figure out how this new interpretation of enablement affects them.

Join us for a webinar with Yvonne Shyntum, Partner at PABST Patent Group, as she walks through the Court's interpretation of enablement and practical strategies for complying with enablement. Dr. Shyntum holds a Ph.D. in Molecular and Systems Pharmacology from Emory University and a J.D. from Georgia State University. She represents clients in the biotechnology and pharmaceutical areas and regularly presents on intellectual property topics. 

Register here.